drugset / Trial / NCT04453189
A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants
RandomizedCrossoverOpen-labelOther
Summary
The primary purpose of this study is to evaluate the effect of multiple-dose administration of lansoprazole on the single-dose pharmacokinetics (PK) of JNJ-64417184 in healthy adult participants; and to evaluate the effect of time-separated, multiple-dose administration of famotidine on the single-dose PK of JNJ-64417184 in healthy adult participants (optional).
Timeline
- Start
- 2020-07-20
- Primary completion
- 2020-09-14
- Completion
- 2020-09-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Famotidine | Other / unclassified | — | — |
| Subject | JNJ-64417184 | Unknown | — | Oral |
| Subject | Lansoprazole | Other / unclassified | — | — |
Indications
No indication recorded.